Rapt Therapeutics, Inc. (RAPT)
35.28
+0.34
(+0.97%)
USD |
NASDAQ |
Dec 09, 16:00
35.28
0.00 (0.00%)
After-Hours: 20:00
Rapt Therapeutics Market Cap: 583.45M for Dec. 9, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Replimune Group, Inc. | 808.36M |
| Olema Pharmaceuticals, Inc. | 1.825B |
| NovaBay Pharmaceuticals, Inc. | 229.34M |
| Palatin Technologies, Inc. | 25.56M |
| Theriva Biologics, Inc. | 7.402M |
Market Cap Related Metrics
| PEG Ratio | -0.0121 |
| Price to Book Value | 3.839 |
| Price | 35.28 |
| Earnings Yield | -29.79% |
| PEGY Ratio | -0.0121 |